Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.7B | 1.7B | 1.7B | 1.6B |
| Cost of revenue | 802M | 782M | 785M | 723M |
| Gross profit | 866M | 899M | 916M | 855M |
| Operating expense | ||||
| Research & development | 112M | 113M | 111M | 127M |
| Selling general and admin | 454M | 410M | 397M | 395M |
| Other operating expenses | — | — | — | — |
| Operating income | 300M | 376M | 408M | 333M |
| Non operating interest income | ||||
| Income | 14M | 15M | 24M | 19M |
| Expense | 29M | 28M | 32M | 22M |
| Other income expense | -25M | 4M | 1M | 13M |
| Pretax income | 260M | 367M | 401M | 343M |
| Tax provision | 45M | 49M | 50M | 61M |
| Net income | 215M | 318M | 351M | 282M |
| Basic EPS | 0.8 | 1.1 | 1.2 | 1.0 |
| Diluted EPS | 0.8 | 1.1 | 1.2 | 1.0 |
| Basic average shares | 285M | 285M | 286M | 290M |
| Diluted average shares | 285M | 287M | 287M | 291M |
| EBITDA | 362M | 467M | 502M | 428M |
| Net income from continuing op. | 215M | 318M | 351M | 282M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |